Hedberg Elizabeth L, Shih Charles K, Solchaga Luis A, Caplan Arnold I, Mikos Antonios G
Department of Bioengineering, Rice University, P.O. Box 1892, MS-142, Houston, TX 77251-1892, USA.
J Control Release. 2004 Nov 24;100(2):257-66. doi: 10.1016/j.jconrel.2004.08.020.
In the present study, biodegradable microparticles of blends of poly(DL-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) were explored as a potential carrier for the controlled release of polysaccharide oligomers. To this end, hyaluronan (HY) oligomers of varying molecular weights were incorporated into PLGA/PEG microparticles. Using a two-level fractional factorial experimental design, four microparticle formulation parameters, the amount of PEG included in the microparticles, the initial HY loading of the microparticles, the molecular weight of HY, and the molecular weight of PLGA, were studied for their influence on the incorporation and in vitro release of HY over the period of 28 days. The entrapment efficiencies were found to range between 10+/-1% and 24+/-2% depending on the initial loading and the molecular weight of the HY oligomer used in the fabrication of the microparticles. The HY was released in a multiphasic fashion including an initial burst release, followed by two separate periods of linear release. The normalized cumulative mass released during the burst release ranged from 25.1+/-9.2% to 93.0+/-0.7% and was found to be significantly influenced by the initial HY loading, the HY molecular weight, and the PLGA molecular weight. The initial period of linear release lasted from day 1 to day 14 and displayed normalized cumulative rates of release from 0.1+/-0.0%/day to 1.4+/-0.2%/day. During this period, PEG content of the microparticles and HY molecular weight exerted the greatest influence on the rate of release. Finally, the second period of linear release lasted through the final time-point at day 28. Here, the normalized cumulative rate of release values ranged from 0.2+/-0.1%/day to 3.6+/-0.7%/day and were dependent on all formulation parameters studied. These results demonstrate the potential of PLGA/PEG blend microparticles for the controlled release of HY oligomers.
在本研究中,探索了聚(DL-乳酸-共-乙醇酸)(PLGA)与聚乙二醇(PEG)共混物的可生物降解微粒作为多糖低聚物控释的潜在载体。为此,将不同分子量的透明质酸(HY)低聚物掺入PLGA/PEG微粒中。采用两水平部分因子实验设计,研究了微粒中PEG的含量、微粒的初始HY载量、HY的分子量以及PLGA的分子量这四个微粒配方参数对28天内HY的包封率和体外释放的影响。根据微粒制备中所用HY低聚物的初始载量和分子量,发现包封率在10±1%至24±2%之间。HY以多相方式释放,包括初始的突释,随后是两个独立的线性释放期。突释期间的归一化累积释放质量范围为25.1±9.2%至93.0±0.7%,并且发现其受到初始HY载量、HY分子量和PLGA分子量的显著影响。线性释放的初始阶段从第1天持续到第14天,归一化累积释放率为0.1±0.0%/天至1.4±0.2%/天。在此期间,微粒的PEG含量和HY分子量对释放速率影响最大。最后,线性释放的第二阶段持续到第28天的最后时间点。在此,归一化累积释放率值范围为0.2±0.1%/天至3.6±0.7%/天,并且取决于所研究的所有配方参数。这些结果证明了PLGA/PEG共混微粒用于HY低聚物控释的潜力。